Skip to main content
. 2020 Mar 26;7(1):e000368. doi: 10.1136/bmjgast-2019-000368

Table 5.

Proportion of patients with controlled (<5.0) and uncontrolled (≥5.0) levels of TC (mmol/L) throughout the study in both subgroups: post hoc analysis

Lipid-lowering drug treatment (n=766) Baseline 12 weeks 24 weeks
TC<5.0 mmol/L 23 (3.0) 86 (11.2) 279 (36.4)
TC≥5.0 mmol/L 740 (96.6) 660 (86.2) 480 (62.7)
Unavailable data 3 (0.4) 20 (2.6) 7 (0.9)
No lipid-lowering drug treatment (n=2077) Baseline 12 weeks 24 weeks
TC<5.0 mmol/L 370 (17.8) 482 (23.2) 691 (33.3)
TC≥5.0 mmol/L 1653 (79.6) 1387 (66.8) 1240 (59.7)
Unavailable data 54 (2.6) 208 (10.0) 146 (7.0)

Data are expressed as n (%). Percentages are calculated as n/N.

TC, total cholesterol.